Munehiro Ito
Impact in
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
- Lung Cancer Research Studies
- Colorectal Cancer Treatments and Studies
- CAR-T cell therapy research
-
- Lung Cancer Treatments and Mutations
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Lung Cancer Diagnosis and Treatment
Papers in
-
- Lung Cancer Treatments and Mutations 5
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 3
- Lung Cancer Diagnosis and Treatment 2
- Brain Metastases and Treatment 1
- Oncology 9
- Cancer Immunotherapy and Biomarkers 6
- Pancreatic and Hepatic Oncology Research 2
- HER2/EGFR in Cancer Research 2
- Co-authors
- Keisuke Tomii (9 shared papers)Daichi Fujimoto (9 shared papers)Kazuma Nagata (7 shared papers)Kojiro Otsuka (7 shared papers)Atsushi Nakagawa (7 shared papers)Yuki Sato (7 shared papers)Shunsuke Teraoka (6 shared papers)Takeshi Morimoto (5 shared papers)
- Journals
- Clinical Lung Cancer (2 papers)Lung Cancer (2 papers)Journal of Thoracic Oncology (2 papers)Frontiers in Oncology (1 paper)Scientific Reports (1 paper)
- Partner nations
- JapanUnited States
In The Last Decade
Munehiro Ito
14 papers receiving 540 citations
Peers
Comparison fields: 5 of 43
- Oncology 481
- Pulmonary and Respiratory Medicine 317
- Immunology 81
- Cancer Research 31
- Genetics 21
Countries citing papers authored by Munehiro Ito
This map shows the geographic impact of Munehiro Ito's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Munehiro Ito with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Munehiro Ito more than expected).
Fields of papers citing papers by Munehiro Ito
This network shows the impact of papers produced by Munehiro Ito. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Munehiro Ito. The network helps show where Munehiro Ito may publish in the future.
Co-authors
The 25 scholars most cited alongside Munehiro Ito, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 293 | |
| 2 | 2017 | 68 | |
| 3 | 2017 | 58 | |
| 4 | 2017 | 44 | |
| 5 | 2018 | 26 | |
| 6 | 2019 | 16 | |
| 7 | 2018 | 11 | |
| 8 | 2020 | 7 | |
| 9 | 2017 | 6 | |
| 10 | 2020 | 4 | |
| 11 | 2020 | 3 | |
| 12 | 2024 | 2 | |
| 13 | 2024 | 2 | |
| 14 | 2016 | 1 |
About Munehiro Ito
Munehiro Ito is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Hematology, Cancer Research and Surgery, having authored 14 papers that have together received 541 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (6 papers), Lung Cancer Treatments and Mutations (5 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (3 papers), Cancer Genomics and Diagnostics (2 papers), Lung Cancer Diagnosis and Treatment (2 papers), Pancreatic and Hepatic Oncology Research (2 papers), HER2/EGFR in Cancer Research (2 papers) and Brain Metastases and Treatment (1 paper). The work is most often cited by research in Oncology (481 citations), Pulmonary and Respiratory Medicine (317 citations), Immunology (81 citations), Cancer Research (31 citations) and Genetics (21 citations). Munehiro Ito has collaborated with scholars based in Japan and United States. Frequent co-authors include Keisuke Tomii, Daichi Fujimoto, Kazuma Nagata, Kojiro Otsuka, Atsushi Nakagawa, Yuki Sato, Shunsuke Teraoka, Takeshi Morimoto, Yukihiro Imai and Keiichiro Uehara. Their work appears in journals such as Clinical Lung Cancer, Lung Cancer, Journal of Thoracic Oncology, Frontiers in Oncology and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.